UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Amyloid blood biomarker detects Alzheimer's disease

EMBO molecular medicine, 2018-05, Vol.10 (5), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Aβ and tau structure-based biomarkers for a blood- and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.257-263

2019

Link zum Volltext

Verfügbarkeit prüfen

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline

Alzheimer's research & therapy, 2020-12, Vol.12 (1), p.169-169, Article 169

2020

Link zum Volltext

Verfügbarkeit prüfen

Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development

Acta neuropathologica communications, 2020-12, Vol.8 (1), p.222-222, Article 222

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer's disease

Translational psychiatry, 2021-05, Vol.11 (1), p.261-261, Article 261

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline

Alzheimer's research & therapy, 2021-01, Vol.13 (1), p.25-25, Article 25

2021

Link zum Volltext

Verfügbarkeit prüfen

Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12151-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

Alzheimer's & dementia, 2023-03, Vol.19 (3), p.1020-1028

2023

Link zum Volltext

Verfügbarkeit prüfen

Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer’s Disease

Analytical chemistry (Washington), 2016-03, Vol.88 (5), p.2755-2762

2016

Link zum Volltext

Verfügbarkeit prüfen

The Effect of (−)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure

Biophysical journal, 2020-07, Vol.119 (2), p.349-359

2020

Link zum Volltext

Verfügbarkeit prüfen

The Effect of (-)-Epigallocatechin-3-Gallate on the Aβ Secondary Structure

Biophysical journal, 2020-02, Vol.118 (3), p.47a-47a

2020

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors

Alzheimer's & dementia, 2020-02, Vol.16 (2), p.283-291

2020

Link zum Volltext

Verfügbarkeit prüfen

FTIR-Spectroscopic Analysis of Proteins in Liquid Samples

Biophysical journal, 2014-01, Vol.106 (2), p.208a-209a

2014

Link zum Volltext

Verfügbarkeit prüfen

An infrared sensor analysing label-free the secondary structure of the Abeta peptide in presence of complex fluids

Journal of biophotonics, 2016-03, Vol.9 (3), p.224-234

2016

Link zum Volltext

Verfügbarkeit prüfen

An ATR-FTIR based Immuno-Biosensor for the Detection and Analysis of Disease Related Biomarkers from Liquid Samples

Biophysical journal, 2015-01, Vol.108 (2), p.482a-482a

2015

Link zum Volltext

Verfügbarkeit prüfen

Immobilization of Proteins on Chemically Modified Germanium Investigated by ATR-FTIR

Biophysical journal, 2015-01, Vol.108 (2), p.345a-345a

2015

Link zum Volltext

Verfügbarkeit prüfen

Reversible Immuno-Infrared Sensor for the Detection of Alzheimer’s Disease Related Biomarkers

ACS sensors, 2019-07, Vol.4 (7), p.1851-1856

2019

Link zum Volltext

Verfügbarkeit prüfen

A[beta] misfolding in blood plasma is inversely associated with body mass index even in middle adulthood

Alzheimer's research & therapy, 2021-08, Vol.13 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Immobilization of Proteins in their Physiological Active State at Functionalized Thiol Monolayers on ATR-Germanium Crystals

Chembiochem : a European journal of chemical biology, 2014-11, Vol.15 (17), p.2529-2534

2014

Link zum Volltext

Verfügbarkeit prüfen

Chemical Functionalization of Germanium with Dextran Brushes for Immobilization of Proteins Revealed by Attenuated Total Reflection Fourier Transform Infrared Difference Spectroscopy

Analytical chemistry (Washington), 2015-07, Vol.87 (14), p.7467-7475

2015

Link zum Volltext

Verfügbarkeit prüfen

Amyloid-[Beta]-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer's Disease

Analytical chemistry (Washington), 2016-03, Vol.88 (5), p.2755

2016

Link zum Volltext

Verfügbarkeit prüfen

An ATR–FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ

ACS medicinal chemistry letters, 2017-07, Vol.8 (7), p.710-714

2017

Link zum Volltext

Verfügbarkeit prüfen

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis

Annals of clinical and translational neurology, 2021-01, Vol.8 (1), p.271-277

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Amyloid-[beta] misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.(Correction notice)

Alzheimer's research & therapy, 2021-01, Vol.13 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Amyloid-[beta] misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline

Alzheimer's research & therapy, 2020-12, Vol.12 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Amyloid blood biomarker detects Alzheimer's disease

Aβ and tau structure-based biomarkers for a blood- and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline

Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development

Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer's disease

Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline

Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease

Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer’s Disease

The Effect of (−)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure

The Effect of (-)-Epigallocatechin-3-Gallate on the Aβ Secondary Structure

Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors

FTIR-Spectroscopic Analysis of Proteins in Liquid Samples

An infrared sensor analysing label-free the secondary structure of the Abeta peptide in presence of complex fluids

An ATR-FTIR based Immuno-Biosensor for the Detection and Analysis of Disease Related Biomarkers from Liquid Samples

Immobilization of Proteins on Chemically Modified Germanium Investigated by ATR-FTIR

Reversible Immuno-Infrared Sensor for the Detection of Alzheimer’s Disease Related Biomarkers

A[beta] misfolding in blood plasma is inversely associated with body mass index even in middle adulthood

Immobilization of Proteins in their Physiological Active State at Functionalized Thiol Monolayers on ATR-Germanium Crystals

Chemical Functionalization of Germanium with Dextran Brushes for Immobilization of Proteins Revealed by Attenuated Total Reflection Fourier Transform Infrared Difference Spectroscopy

Amyloid-[Beta]-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer's Disease

An ATR–FTIR Sensor Unraveling the Drug Intervention of Methylene Blue, Congo Red, and Berberine on Human Tau and Aβ

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis

Correction to: Amyloid-[beta] misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.(Correction notice)

Amyloid-[beta] misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline

Suchergebnisse filtern